Prince Frederick Dental Center now offers a New Approach to Managing Postsurgical Pain With an Important Non-Opioid Option
In an effort to provide an improved postsurgical recovery experience for patients and curb the use of opioid pain medications, We recently adopted a novel approach to managing postsurgical pain. Known as multimodal pain management, this change in approach demonstrates the proactive stance we are taking against the overreliance on opioids.
The new operating room regimen uses a combination of non-opioid pain medications before, during, and after surgery to effectively control postsurgical pain while helping patients remain alert and comfortable during their recovery. Multimodal therapy is advocated by leading health care organizations, such as the American Pain Society, the American Society of Anesthesiologists, the American Dental Association, the American College of Surgeons, and the Centers for Disease Control and Prevention.
An important part of the multimodal pain management regimen is EXPAREL® (bupivacaine liposome injectable suspension). EXPAREL is a proven, long-acting, non-opioid, numbing medication that is administered into the tissues around the surgical site to control pain and reduce the need for opioids.* EXPAREL is indicated for single-dose infiltration in adults to produce postsurgical local analgesia and as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. Surgeons and anesthesiologists at [Institution name] have been using EXPAREL, in combination with other non-opioid pain medications, in soft tissue (eg, [Insert surgery types in which the institution specializes]) and orthopedic surgeries. More than 5 million patients have received EXPAREL since 2012.
“Traditionally, opioid pain medications have been the first line of defense against postsurgical pain, despite causing side effects that can detract from a patient’s recovery experience,” said Dr [First and last name], [Title] at [Institution name]. “We are proud to be one of the first hospitals in the region to adopt EXPAREL as part of an opioid-minimizing treatment strategy. EXPAREL is administered before patients even wake up from surgery. A single dose can help control their pain and may decrease their need for opioid medications, while providing a proven safety and tolerability profile.”
For more information about [Institution name]’s pain management approach, visit call us at 410-535-5055.
*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.
About EXPAREL
EXPAREL is indicated for single-dose infiltration in adults to produce postsurgical local analgesia and as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks. EXPAREL uses a unique DepoFoam® drug delivery system designed to deliver a proven non-opioid ingredient—called bupivacaine—over time. This slow release makes it possible for EXPAREL to provide long-lasting pain control after surgery with just a single dose. Clinical studies with EXPAREL demonstrated significant reductions in pain scores and consumption of opioids. Additional information is available at www.EXPAREL.com.
Indication
EXPAREL® (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in adults to produce postsurgical local analgesia and as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.
Important Safety Information
EXPAREL should not be used in obstetrical paracervical block anesthesia.
In studies where EXPAREL was injected into the wound, the most common side effects were nausea, constipation, and vomiting.
In studies where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, and constipation.
EXPAREL is not recommended to be used in patients younger than 18 years old or in pregnant women.
Tell your healthcare provider if you have liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from your body.
EXPAREL should not be injected into the spine, joints, or veins.
The active ingredient in EXPAREL:
• Can affect your nervous system and your cardiovascular system
• May cause an allergic reaction
• May cause damage if injected into your joints
• Can cause a rare blood disorder
Please refer to the full Prescribing Information here.
For more information, please visit www.EXPAREL.com/patient or call 1-855-RX-EXPAREL (793-9727).